Clinical Trials Sponsored by Institute AllergoSan

Total 75226 results

Allergan

Terminated

Evaluation of the Safety and Effectiveness of BELKYRA® Inj. for the Treatment of Patients With Submental Fullness Due to Submental Fat: A Postmarketing Surveillance Study in Korea

Submental Fullness

Korea, Republic of
Allergan

Completed

Chart Review of XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)

Glaucoma

United States
Allergan

Completed

A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD)

Macular Degeneration

United States
Allergan

Completed

Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Acute Bacterial Skin and Skin Structure Infections

United States
Allergan

Completed

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

United States, Israel, Canada, Singapore, Philippines, Spain, Australia, Belgium, Brazil, Germany
Allergan

Completed

Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal Neurostimulation

Dry Eye Syndromes

United States
Allergan

Completed

Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea

Erythema | Rosacea

United States
Allergan

Completed

AGN-199201 for the Treatment of Erythema With Rosacea

Erythema | Rosacea

United States
Allergan

Completed

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

Cerebral Palsy | Muscle Spasticity | Pediatrics

United States, Korea, Republic of, Thailand, Philippines, Poland, Hungary, Russian Federation, Turkey, Italy
Allergan

Completed

A Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula

Age-related Volume Deficit in the Mid-face

United States
Allergan

Terminated

Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye (Louvre 2)

Non-infectious Uveitis

France
Allergan

Completed

Evaluation of Age-Related Skin Changes

Age-related Skin Changes

France
Allergan

Completed

Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis

Eyelash Hypotrichosis

Japan
Allergan

Completed

Study to Assess the Cosmetic Changes in the Facial Skin After Use of a Topical Retinoid Product in Participants With Moderate to Severe Photodamage

Skin Care

United States
Allergan

Completed

Botulinum Toxin Type A (BOTOX®) Treatment of Masseter Muscle Hypertrophy

Masseter Muscle Hypertrophy

Taiwan, Australia, Canada
Allergan

Completed

Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)

Multiple Sclerosis | Urinary Incontinence | Neurogenic Bladder

France, Poland, Portugal, Belgium, Canada, Russian Federation, Czechia, United States
Allergan

Completed

A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons

Ocular Hypertension | Glaucoma, Primary Open Angle

Germany
Allergan

Completed

A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting

Ocular Hypertension | Glaucoma, Primary Open Angle

Germany
Allergan

Completed

A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye

Dry Eye Syndromes | Keratoconjunctivitis Sicca

France, United Kingdom
Allergan

Completed

An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments

Ocular Hypertension | Glaucoma, Open-Angle

Turkey
Allergan

Completed

An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A

Facial Rhytides

Argentina
Allergan

Completed

Safety and Efficacy of Punctal Plug Insertion in Patients With Dry Eye

Dry Eye

Singapore
Allergan

Completed

A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema

Macular Edema

Canada
Allergan

Completed

A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion (COBALT)

Macular Edema | Retinal Vein Occlusion

Korea, Republic of
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines

Glabellar Frown Lines | Facial Rhytides

Canada
Allergan

Completed

Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease

Dry Eye Syndromes

Canada, Australia
Allergan

Completed

Post-Market Study of JUVÉDERM VOLIFT™ With Lidocaine for the Correction of Nasolabial Folds

Moderate to Severe Nasolabial Folds

Germany, Netherlands
Allergan

Completed

JUVEDERM® Ultra XC vs. Belotero Balance® for Perioral Lines

Patients With Moderate to Severe Perioral Lines

United States
Allergan

Completed

A Prospective, Open Label Study Evaluating JUVÉDERM® VOLBELLA With Lidocaine Treatment for the Correction of Skin Depressions in the Infra-orbital Area

Infra-orbital Skin Depressions

France
Allergan

Completed

A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males

Alopecia

United States
Allergan

Completed

Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease

Dry Eye Syndromes

United States
Allergan

Completed

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine (ACHIEVE II)

Migraine, With or Without Aura

United States
Allergan

Completed

Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use

Irritable Bowel Syndrome With Diarrhea

United States, Canada
Allergan

Completed

An Adult Spasticity Registry of OnabotulinumtoxinA Treatment (ASPIRE)

Muscle Spasticity

Spain, Italy, United States, Germany, United Kingdom, Taiwan, France
Allergan

Completed

Study to Evaluate Efficacy and Tolerability of Two Topical Regimens in Subjects With Moderate to Severe Facial Photodamage Who Have Received Cosmetic Injections

Facial Photodamage

United States
Allergan

Completed

Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects

Eyelash Hypotrichosis

Korea, Republic of
Allergan

Completed

Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines

Skin Aging

United States
Allergan

Completed

Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

Glabellar Lines | Nasolabial Fold | Crow's Feet Lines | Facial Rhytides

United States
Allergan

Completed

A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006)

Migraine
Allergan

Completed

Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Participants With Moderate Facial Melasma

Melasma

United States
Allergan

Completed

An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine

Migraine Disorders

Spain, Germany, Italy, Norway, Russian Federation, Sweden, United Kingdom
Allergan

Terminated

A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation

Premature Ejaculation

United States, United Kingdom
Allergan

Completed

A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions

Ulcer | Cystitis, Interstitial

United States, Canada
Allergan

Completed

Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD)

Macular Degeneration

Korea, Republic of, Australia, Portugal, Germany, United States, Philippines, Italy
Allergan

Completed

BOTOX® Treatment in Pediatric Lower Limb Spasticity

Cerebral Palsy | Muscle Spasticity | Pediatrics

United States, Korea, Republic of, Thailand, Hungary, Italy, Philippines, Poland, Russian Federation, Turkey
Allergan

Completed

BOTOX® Treatment in Pediatric Upper Limb Spasticity

Stroke | Cerebral Palsy | Muscle Spasticity | Pediatrics

United States, Korea, Republic of, Thailand, Hungary, Poland, Russian Federation, Turkey, Canada, Philippines
Allergan

Completed

Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

China
Allergan

Completed

A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India

Overactive Bladder | Urinary Incontinence

India

3

Subscribe